CEST-mDixon imaging utilizing hydroxyl and amine pools could aid breast tumor diagnosis, as shown in previous preliminary studies. In the current study, CEST-mDixon is evaluated in a breast cancer patient cohort using improved saturation and acquisition parameters. The results agree with previous findings demonstrating moderate linear correlation of CEST effects at 1 ppm and 2 ppm with Ki-67. In addition, we observe a linear correlation with the percentage of cells positive for nuclear expression of the progesterone receptor (PR), the first such observation reported. Overall, the study confirms the potential for CEST-mDixon for characterizing breast tumor aggressiveness non-invasively.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords